Key result
XIENCE SBA everolimus-eluting system features in a comprehensive overview of recent advancements in cardiovascular interventions.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Highlights XIENCE SBA as a potential bifurcation option; leaves open the need for dedicated trials before adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sorop et al. (2010) studied this question. The XIENCE SBA dedicated everolimus-eluting side branch access system is featured as a recent advancement in a comprehensive overview of modern cardiovascular interventions.
Synapse has enriched 10 related papers. Consider them for comparative context: